Downregulation of Ezh2 expression by RNA interference induces cell cycle arrest in the G0/G1 phase and apoptosis in U87 human glioma cells

Oncology Reports

Volumn 28, Issue 6, 2012, Pages 2278-2284

  Zhang, Ruijian ^a   Wang, Ruijun ^b   Chang, Hong ^a   Wu, Fei ^c   Liu, Chuntao ^c   Deng, Dongfeng ^c   Fan, Wenhai ^c  

^a INNER MONGOLIA PEOPLE S HOSPITAL   (China)

^b INNER MONGOLIA MEDICAL COLLEGE   (China)

^c DALIAN UNIVERSITY   (China)

Author keywords

Apoptosis; Ezh2; Glioma; Mitochondria; RNA interference

Indexed keywords

CASPASE 3; CASPASE 9; CYTOCHROME C; PROTEIN BAX; PROTEIN BCL 2; TRANSCRIPTION FACTOR EZH2;

APOPTOSIS; CANCER GROWTH; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CELLULAR SECRETION; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVATION; EZH2 GENE; GENE; GENE EXPRESSION REGULATION; GENE SILENCING; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; MITOCHONDRIAL MEMBRANE POTENTIAL; PRIORITY JOURNAL; PROTEIN SECRETION; RNA INTERFERENCE;

APOPTOSIS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CASPASE 9; CELL LINE, TUMOR; CYTOCHROMES C; DOWN-REGULATION; G1 PHASE CELL CYCLE CHECKPOINTS; GLIOMA; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; POLYCOMB REPRESSIVE COMPLEX 2; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 84868087652     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.2033     Document Type: Conference Paper

References (30)

1. Johannesen TB, Langmark F and Lote K: Cause of death and long-term survival in patients with neuro-epithelial brain tumours: a population-based study. Eur J Cancer 39:2355-2363, 2003. (Pubitemid 37214860)
2. Hess KR, Broglio KR and Bondy ML: Adult glioma incidence trends in the United States, 1977-2000. Cancer 101:2293-2299, 2004. (Pubitemid 39458686)
3. Stummer W and Kamp MA: The importance of surgical resection in malignant glioma. Curr Opin Neurol 22:645-649, 2009.
4. Norden AD and Wen PY: Glioma therapy in adults. Neurologist 12:279-292, 2006. (Pubitemid 44813664)
5. De Haan G and Gerrits A: Epigenetic control of hematopoietic stem cell aging the case of Ezh2. Ann NY Acad Sci 1106:233-239, 2007. (Pubitemid 47443044)
6. Venneti S, Le P, Martinez D, Xie SX, Sullivan LM, Rorke-Adams LB, Pawel B and Judkins AR: Malignant rhabdoid tumors express stem cell factors, which relate to the expression of EZH2 and Id proteins. Am J Surg Pathol 35:1463-1472, 2011.
7. Juan AH, Derfoul A, Feng X, Ryall JG, Dell'Orso S, Pasut A, Zare H, Simone JM, Rudnicki MA and Sartorelli V: Polycomb EZH2 controls self-renewal and safeguards the transcriptional identity of skeletal muscle stem cells. Genes Dev 25:789-794, 2011.
8. Yonemitsu Y, Imazeki F, Chiba T, Fukai K, Nagai Y, Miyagi S, Arai M, Aoki R, Miyazaki M, Nakatani Y, et al: Distinct expression of polycomb group proteins EZH2 and BMI1 in hepatocellular carcinoma. Hum Pathol 40:1304-1311, 2009.
9. Reijm EA, Jansen MP, Ruigrok-Ritstier K, Van Staveren IL, Look M P, Van Gelder ME, Sieuwerts AM, Sleijfer S, Foekens JA and Berns EM: Decreased expression of EZH2 is associated with upregulation of ER and favorable outcome to tamoxifen in advanced breast cancer. Breast Cancer Res Treat 125:387-394, 2011.
10. Hinz S, Weikert S, Magheli A, Hoffmann M, Engers R, Miller K and Kempkensteffen C: Expression profile of the polycomb group protein enhancer of Zeste homologue 2 and its prognostic relevance in renal cell carcinoma. J Urol 182:2920-2925, 2009.
11. Varambally S, Dhanasekaran SM, Zhou M, Barrette TR, Kumar-Sinha C, Sanda MG, Ghosh D, Pienta KJ, Sewalt RG, Otte AP, et al: The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 419:624-629, 2002.
12. Visser HP, Gunster MJ, Kluin-Nelemans HC, Manders EM, Raaphorst FM, Meijer CJ, Willemze R and Otte AP: The Polycomb group protein EZH2 is upregulated in proliferating, cultured human mantle cell lymphoma. Br J Haematol 112:950-958, 2001. (Pubitemid 32322920)
13. Smits M, Nilsson J, Mir SE, Van Der Stoop PM, Hulleman E, Niers JM, De Witt Hamer PC, Marquez VE, Cloos J, Krichevsky AM, et al: miR-101 is down-regulated in glioblastoma resulting in EZH2-induced proliferation, migration, and angiogenesis. Oncotarget 1:710-720, 2010.
14. Tomiyama A, Tachibana K, Suzuki K, Seino S, Sunayama J, Matsuda KI, Sato A, Matsumoto Y, Nomiya T, Nemoto K, et al: MEK-ERK-dependent multiple caspase activation by mitochondrial proapoptotic Bcl-2 family proteins is essential for heavy ion irradiation-induced glioma cell death. Cell Death Dis 1:e60, 2010.
15. Qiao S, Murakami K, Zhao Q, Wang B, Seo H, Yamashita H, Li X, Iwamoto T, Ichihara M and Yoshino M: Mimosineinduced apoptosis in C6 glioma cells requires the release of mitochondria-derived reactive oxygen species and p38, JNK activation. Neurochem Res 37:417-427, 2012.
16. Lu HF, Chie YJ, Yang MS, Lee CS, Fu JJ, Yang JS, Tan TW, Wu SH, Ma YS, Ip SW and Chung JG: Apigenin induces caspasedependent apoptosis in human lung cancer A549 cells through Bax-and Bcl-2-triggered mitochondrial pathway. Int J Oncol 36:1477-1484, 2010.
17. Tang B, Zhang Y, Liang R, Yuan P, Du J, Wang H and Wang L: Activation of the δ-opioid receptor inhibits serum deprivationinduced apoptosis of human liver cells via the activation of PKC and the mitochondrial pathway. Int J Mol Med 28:1077-1085, 2011.
18. Dang X, Ma A, Yang L, Hu H, Zhu B, Shang D, Chen T and Luo Y: MicroRNA-26a regulates tumorigenic properties of EZH2 in human lung carcinoma cells. Cancer Genet 205:113-123, 2012.
19. Esposito F, Tornincasa M, Pallante P, Federico A, Borbone E, Pierantoni GM and Fusco A: Down-regulation of the miR-25 and miR-30d contributes to the development of anaplastic thyroid carcinoma targeting the polycomb protein EZH2. J Clin Endocrinol Metab 97:E710-E718, 2012.
20. Fussbroich B, Wagener N, Macher-Goeppinger S, Benner A, Fälth M, Sültmann H, Holzer A, Hoppe-Seyler K and Hoppe-Seyler F: EZH2 depletion blocks the proliferation of colon cancer cells. PLoS One 6:e21651, 2011.
21. Li H, Cai Q, Godwin AK and Zhang R: Enhancer of zeste homolog 2 promotes the proliferation and invasion of epithelial ovarian cancer cells. Mol Cancer Res 8:1610-1618, 2010.
22. Ougolkov AV, Bilim VN and Billadeau DD: Regulation of pancreatic tumor cell proliferation and chemoresistance by the histone methyltransferase enhancer of zeste homologue 2. Clin Cancer Res 14:6790-6796, 2008.
23. Wagener N, Holland D, Bulkescher J, Crnkovic-Mertens I, Hoppe-Seyler K, Zentgraf H, Pritsch M, Buse S, Pfitzenmaier J, Haferkamp A, et al: The enhancer of zeste homolog 2 gene contributes to cell proliferation and apoptosis resistance in renal cell carcinoma cells. Int J Cancer 123:1545-1550, 2008.
24. Wu ZL, Zheng SS, Li ZM, Qiao YY, Aau MY and Yu Q: Polycomb protein EZH2 regulates E2F1-dependent apoptosis through epigenetically modulating Bim expression. Cell Death Differ 17:801-810, 2010.
25. Wu SC and Zhang Y: Cyclin-dependent kinase 1 (CDK1) - mediated phosphorylation of enhancer of zeste 2 (Ezh2) regulates its stability. J Biol Chem 286:28511-28519, 2011.
26. Chen S, Bohrer LR, Rai AN, Pan Y, Gan L, Zhou X, Bagchi A, Simon JA and Huang H: Cyclin-dependent kinases regulate epigenetic gene silencing through phosphorylation of EZH2. Nat Cell Biol 12:1108-1114, 2010.
27. Von Haefen C, Wendt J, Semini G, Sifringer M, Belka C, Radetzki S, Reutter W, Daniel PT and Danker K: Synthetic glycosidated phospholipids induce apoptosis through activation of FADD, caspase-8 and the mitochondrial death pathway. Apoptosis 16:636-651, 2011.
28. Mattson MP and Kroemer G: Mitochondria in cell death: novel targets for neuroprotection and cardioprotection. Trends Mol Med 9:196-205, 2003. (Pubitemid 36713389)
29. Saito M, Korsmeyer SJ and Schlesinger PH: BAX-dependent transport of cytochrome c reconstituted in pure liposomes. Nat Cell Biol 2:553-555, 2000.
30. Riedl SJ and Shi Y: Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol Cell Biol 5:897-907, 2004. (Pubitemid 39486541)